NCT07020299

Brief Summary

Respiratory muscle dysfunction is a common consequence of chronic obstructive pulmonary disease (COPD). This technique consists of placing electrodes on the skin at locations near the motor points of the diaphragm, transmitting an intermittent current, and generating action potentials capable of producing muscle contractions

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 27, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

June 13, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

June 13, 2025

Status Verified

June 1, 2025

Enrollment Period

6 months

First QC Date

May 27, 2025

Last Update Submit

June 4, 2025

Conditions

Keywords

chronic obstructive pulmonary disease exacerbationElectrical diaphragmatic stimulation

Outcome Measures

Primary Outcomes (1)

  • The primary outcome is the progression to invasive mechanical ventilation(IMV)

    Functional assessment by US measurement of diaphragmatic excursion and thickness fraction in (cm) including base line measurement and post treatment measurement ( at the end of admission).

    6 months

Secondary Outcomes (1)

  • The secondary outcomes is the duration of ICU admission

    12 months

Study Arms (2)

TEDS group will be subjected to sessions of TEDS

ACTIVE COMPARATOR

TEDS group will be subjected to sessions of TEDS as follow : Digital electrical muscle stimulator (EV-906 Digital TENS/EMS made in TAIWAN) is applied to induce diaphragm contraction.

Device: Device : Digital electrical muscle stimulator is applied to induce diaphragm contraction.

Non TEDS group will not be subjected to sessions of TEDS

NO INTERVENTION

Non TEDS group will not be subjected to sessions of TEDS

Interventions

TEDS group will be subjected to sessions of TEDS as follow : Digital electrical muscle stimulator (EV-906 Digital TENS/EMS made in TAIWAN) is applied to induce diaphragm contraction.

TEDS group will be subjected to sessions of TEDS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18 years.
  • Known cases of COPD admitted at respiratory critical care unit with severe acute exacerbation (defined according to GOLD 2024).

You may not qualify if:

  • Body mass index (BMI) \> 35 kg/m2
  • Post arrest patients
  • Brain death
  • Hemodynamic instability
  • Invasive MV
  • Lung disease other than COPD
  • Pregnancy , ascitis.
  • History of neuromuscular disease at admission
  • Spinal injuries
  • Skin lesions or an open lesion in the regions where the electrodes would be placed
  • Use of pacemakers
  • Patients on maintenance steroid therapy
  • Depletating disease as malignancy 14. Patients refusing the procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of medicine mansoura university

Al Mansurah, 35516, Egypt

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Mohamed AbdElmoniem, lecturer

    Lecturer of chest medicine faculty of medicine Mansoura university

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Masking Details
Participants will be randomly assigned into a TEDS group or control group. Method of randomization : Before participant recruitment, sequential sealed envelopes are prepared by an independent investigator, with one envelope will be chosen randomly by another investigator for each participant.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Effect of trans-cutenuous electrical diaphragmatic stimulation on severe chronic obstructive pulmonary disease exacerbation
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of chest medicine department faculty of medicine mansoura university

Study Record Dates

First Submitted

May 27, 2025

First Posted

June 13, 2025

Study Start

August 1, 2024

Primary Completion

February 1, 2025

Study Completion

August 1, 2025

Last Updated

June 13, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations